91
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts

ORCID Icon, ORCID Icon, &
Pages 321-327 | Received 02 Oct 2017, Accepted 24 Dec 2017, Published online: 16 Jan 2018

References

  • Amata E, Marrazzo A, Dichiara M, Modica MN, Salerno L, Prezzavento O, Nastasi G, Rescifina A, Romeo G, Pittalà V, et al. 2017. Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors. Data Brief. 15:281–299.
  • Atanasova M, Ilieva S, Galabov B. 2007. QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines with anticancer activity. Eur J Med Chem. 42:1184–1192.
  • Benigni R, Bossa C, Netzeva T, Rodomonte A, Tsakovska I. 2007. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens. Environ Mol Mutagen. 48:754–771.
  • Brown R, Chua LO. 1997. Chaos: generating complexity from simplicity. Int J Bifurcation Chaos. 7:2427–2436.
  • Bujak R, Struck-Lewicka W, Kaliszan M, Kaliszan R, Markuszewski MJ. 2015. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR)). J Pharm Biomed Anal. 108:29–37.
  • Cash G. 2001. Prediction of the genotoxicity of aromatic and heteroaromatic amines using electrotopological state indices. Mutat Res. 491:31–37.
  • Ciura K, Belka M, Kawczak P, Bączek T, Markuszewski MJ, Nowakowska J. 2017. Combined computational-experimental approach to predict blood-brain barrier (BBB) permeation based on “green” salting-out thin layer chromatography supported by simple molecular descriptors. J Pharm Biomed Anal. 143:214–221.
  • CORAL. 2016. [accessed 2017 June]. http://www.insilico.eu/CORAL.
  • Heidari A, Fatemi MH. 2017. A theoretical approach to model and predict the adsorption coefficients of some small aromatic molecules on carbon nanotube. J Chinese Chem Soc. 64:289–295.
  • Hou T, Xu X. 2002. ADME evaluation in drug discovery. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs. J Mol Model. 8:337–349.
  • Gobbi M, Beeg M, Toropova MA, Toropov AA, Salmona M. 2016. Monte Carlo method for predicting of cardiac toxicity: hERG blocker compounds. Toxicol Lett. 250–251:42–46.
  • Kumar A, Chauhan S. 2017. QSAR differential model for prediction of SIRT1 modulation using Monte Carlo method. Drug Res. 67:156–162.
  • Limberg J, Seising R. 2009. Fuzzy set theory and the philosophical foundations of medicine. In: Book Kacprzyk J, editor. Studies in Fuzziness and Soft Computing. Berlin, Heidelberg: Springer. Vol. 243; p. 321–44.
  • Li L, Hu J, Ho Y-S. 2014. Global performance and trend of QSAR/QSPR research: a bibliometric analysis. Mol Inform. 33:655–668.
  • Liu Y-H, Zhou Z-X, Zhang X-L, Li HD. 2015. Development of QSAR model for predicting the mutagenicity of aromatic compounds. Chinese J Struct Chem. 34:324–334.
  • Nagpal G, Uddin M, Kaur A. 2012. A comparative study of estimation by Analogy using data mining techniques. J Inf Process Syst. 8:621–652.
  • Rescifina A, Floresta G, Marrazzo A, Parenti C, Prezzavento O, Nastasi G, Dichiara M, Amata E. 2017. Development of a sigma-2 receptor affinity filter through a Monte Carlo based QSAR analysis. Eur J Pharm Sci. 106:94–101.
  • Simon L, Imane A, Srinivasan KK, Pathak L, Daoud I. 2017. In silico drug-designing studies on flavanoids as anticolon cancer agents: pharmacophore mapping, molecular docking, and Monte Carlo method-based QSAR modeling. Interdiscip Sci Comput Life Sci. 9:445–458.
  • Sokolović D, Ranković J, Stanković V, Stefanović R, Karaleić S, Mekić B, Milenković V, Kocić J, Veselinović AM. 2017. QSAR study of dipeptidyl peptidase-4 inhibitors based on the Monte Carlo method. Med Chem Res. 26:796–804.
  • Vieira J, Braga F, Lobato C, Santos C, Costa J, Bittencourt J, Brasil D, Silva J, Hage-Melim L, Macêdo W, et al. 2014. A QSAR, pharmacokinetic and toxicological study of new artemisinin compounds with anticancer activity. Molecules 19:10670–10697.
  • Vijith VS, Harikrishnan KV, Krishnapriya S, Veena Varma, Asha Jose, Prasanna Ramani, Kumar EP, Krishnan Namboori PK. 2013. Design of novel drug molecules for the treatment of breast cancer. Int J Pharm Sci Rev Res 20:113–117.
  • Vineis P. 2008. Methodological insights: fuzzy sets in medicine. J Epidemiol Community Health. 62:273–278.
  • Weininger D. 1988. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Model. 28:31–36.
  • Yang H, Li J, Wu Z, Li W, Liu G, Tang Y. 2017. Evaluation of different methods for identification of structural alerts using chemical ames mutagenicity data set as a benchmark. Chem Res Toxicol. 30:1355–1364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.